Results 201 to 210 of about 86,323 (286)

Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors. [PDF]

open access: yesJCO Precis Oncol
O'Sullivan Coyne G   +19 more
europepmc   +1 more source

Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations. [PDF]

open access: yesJ Cancer Res Clin Oncol
Turaga SM   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy